736 related articles for article (PubMed ID: 27623716)
1. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
2. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
[TBL] [Abstract][Full Text] [Related]
4. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
[TBL] [Abstract][Full Text] [Related]
5. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
Fraser CG
Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
[TBL] [Abstract][Full Text] [Related]
6. Faecal calprotectin is not necessarily required as a screen for significant bowel disease in primary care.
Waite MMA; Langmead L; Ayling RM
Ann Clin Biochem; 2022 May; 59(3):171-177. PubMed ID: 34958262
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
[TBL] [Abstract][Full Text] [Related]
8. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
[TBL] [Abstract][Full Text] [Related]
9. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
10. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
11. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
13. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study.
Kok L; Elias SG; Witteman BJ; Goedhard JG; Muris JW; Moons KG; de Wit NJ
Clin Chem; 2012 Jun; 58(6):989-98. PubMed ID: 22407858
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
[TBL] [Abstract][Full Text] [Related]
16. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
17. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
18. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children.
Sandhu K; Naik S; Ayling RM
Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889
[TBL] [Abstract][Full Text] [Related]
19. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
BMC Fam Pract; 2020 Jul; 21(1):129. PubMed ID: 32611307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]